The Medicines Company to Participate in the Chardan 3rd Annual Genetic Medicines Conference
October 04 2019 - 11:00AM
Business Wire
The Medicines Company (NASDAQ:MDCO) announced that it will
participate in the Chardan 3rd Annual Genetic Medicines Conference
on Tuesday, October 8, 2019, in New York. The Company is scheduled
to participate in a “fireside chat” discussion at 8:00 a.m. Eastern
Daylight Time.
A live audio webcast will be available on The Medicines Company
Investor Relations website and a replay of the presentation will be
available within 48 hours of the event.
About The Medicines Company
The Medicines Company (NASDAQ: MDCO) is a biopharmaceutical
company with a singular, relentless focus on addressing the
greatest global healthcare challenge and burden today –
cardiovascular disease. Our purpose is to halt the deadly
progression of atherosclerosis and the cardiovascular risk created
by high levels of LDL-C. The Company is headquartered in
Parsippany, New Jersey. For more information, please visit
www.themedicinescompany.com and follow us on Twitter @MDCONews and
LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191004005333/en/
Investor Relations Krishna Gorti, M.D. Investor
Relations +1 973 290 6122 krishna.gorti@themedco.com Media
Inquiries Michael Blash Communications +1 973 290 6100
michael.blash@themedco.com
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Medicines (NASDAQ:MDCO)
Historical Stock Chart
From Apr 2023 to Apr 2024